Eubel Brady & Suttman Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Sell
7,329
-76,785
-91% -$17.9M 0.21% 51
2025
Q4
$17.4M Sell
84,114
-57,645
-41% -$11.4M 1.96% 22
2025
Q3
$26.3M Buy
141,759
+458
+0.3% +$78.5K 3.02% 12
2025
Q2
$21.6M Buy
141,301
+2,792
+2% +$429K 2.73% 14
2025
Q1
$23M Buy
138,509
+476
+0.3% +$74.5K 3.02% 12
2024
Q4
$20M Buy
138,033
+2,840
+2% +$440K 2.63% 15
2024
Q3
$21.9M Sell
135,193
-339
-0.3% -$54K 2.86% 11
2024
Q2
$19.8M Buy
135,532
+28,660
+27% +$4.26M 2.87% 12
2024
Q1
$16.9M Buy
106,872
+1,884
+2% +$300K 2.15% 26
2023
Q4
$16.5M Buy
104,988
+71
+0.1% +$10.9K 2.18% 24
2023
Q3
$16.3M Sell
104,917
-45,468
-30% -$7.5M 2.39% 22
2023
Q2
$24.9M Buy
150,385
+2,083
+1% +$336K 3.43% 12
2023
Q1
$23M Buy
148,302
+4,935
+3% +$797K 3.33% 11
2022
Q4
$25.3M Buy
143,367
+1,614
+1% +$279K 4.08% 3
2022
Q3
$23.2M Buy
141,753
+6,701
+5% +$1.13M 4.13% 3
2022
Q2
$24M Sell
135,052
-369
-0.3% -$65.7K 4.8% 3
2022
Q1
$24M Buy
135,421
+5,142
+4% +$875K 4.41% 5
2021
Q4
$22.3M Buy
130,279
+3,364
+3% +$551K 4.37% 6
2021
Q3
$20.5M Buy
126,915
+5,110
+4% +$872K 4.26% 7
2021
Q2
$20M Sell
121,805
-121,805
-50% -$20.2M 1.75% 7
2021
Q1
$40M Buy
243,610
+122,350
+101% +$19.8M 4.37% 5
2020
Q4
$19.1M Sell
121,260
-2,585
-2% -$381K 4.58% 4
2020
Q3
$18.4M Buy
123,845
+24
+0% +$3.55K 4.91% 4
2020
Q2
$17.4M Sell
123,821
-1,673
-1% -$244K 4.57% 4
2020
Q1
$16.5M Buy
125,494
+1,605
+1% +$228K 4.92% 3
2019
Q4
$18.1M Buy
123,889
+43
+0% +$5.83K 4.83% 2
2019
Q3
$16M Sell
123,846
-1,153
-0.9% -$152K 4.6% 2
2019
Q2
$17.4M Sell
124,999
-669
-0.5% -$92.6K 4.89% 2
2019
Q1
$17.6M Buy
125,668
+747
+0.6% +$100K 5.18% 2
2018
Q4
$16.1M Buy
124,921
+867
+0.7% +$121K 5.28% 2
2018
Q3
$17.1M Buy
124,054
+7
+0% +$930 5.07% 2
2018
Q2
$15.1M Sell
124,047
-994
-0.8% -$124K 4.65% 2
2018
Q1
$16M Sell
125,041
-1,469
-1% -$199K 5.1% 2
2017
Q4
$17.7M Sell
126,510
-5,770
-4% -$804K 5.26% 2
2017
Q3
$17.2M Sell
132,280
-2,611
-2% -$346K 5.28% 2
2017
Q2
$17.8M Sell
134,891
-2,415
-2% -$308K 5.44% 2
2017
Q1
$17.1M Buy
137,306
+657
+0.5% +$78.5K 5.12% 2
2016
Q4
$15.7M Sell
136,649
-1,480
-1% -$171K 4.73% 3
2016
Q3
$16.3M Sell
138,129
-665
-0.5% -$80.7K 5.15% 2
2016
Q2
$16.8M Sell
138,794
-2,497
-2% -$284K 5.59% 2
2016
Q1
$15.3M Sell
141,291
-2,845
-2% -$295K 5.12% 2
2015
Q4
$14.8M Sell
144,136
-2,350
-2% -$236K 4.93% 3
2015
Q3
$13.7M Buy
146,486
+1,227
+0.8% +$119K 4.65% 3
2015
Q2
$14.2M Sell
145,259
-1,585
-1% -$159K 4.65% 4
2015
Q1
$14.8M Sell
146,844
-1,333
-0.9% -$136K 4.52% 4
2014
Q4
$15.5M Sell
148,177
-1,223
-0.8% -$129K 4.77% 2
2014
Q3
$15.9M Sell
149,400
-568
-0.4% -$58.9K 4.76% 2
2014
Q2
$15.7M Sell
149,968
-1,319
-0.9% -$133K 4.5% 2
2014
Q1
$14.9M Sell
151,287
-950
-0.6% -$88.1K 4.2% 2
2013
Q4
$13.9M Sell
152,237
-3,206
-2% -$295K 4.01% 2
2013
Q3
$13.5M Sell
155,443
-7,042
-4% -$632K 3.67% 2
2013
Q2
$14M Buy
+162,485
New +$13.8M 3.83% 2

Other funds holding JNJ

Eubel Brady & Suttman Asset Management's JNJ Position: Q1 2026 in Review

Eubel Brady & Suttman Asset Management reduced its Johnson & Johnson (JNJ) stake by 91% in Q1 2026, selling an estimated $17.9M and leaving 7,329 shares worth $1.79M. The position accounts for 0.21% of the portfolio, ranked #51.

Eubel Brady & Suttman Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $40M in Q1 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Eubel Brady & Suttman Asset Management held 7,329 shares of Johnson & Johnson worth $1.79M as of Q1 2026.
  • Eubel Brady & Suttman Asset Management sold 76,785 Johnson & Johnson shares in Q1 2026, an estimated $17.9M.
  • Johnson & Johnson made up 0.21% of Eubel Brady & Suttman Asset Management's portfolio in Q1 2026, its #51 holding.
  • Eubel Brady & Suttman Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Eubel Brady & Suttman Asset Management's Johnson & Johnson position peaked at $40M in Q1 2021.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q1 2026, filed 11 May 2026.